Switzerland

Back to Search

International Partner Search

Research & Development Request

Horizon 2020- MSCA-ITN-ETN European Training Networks: Pharma and Biotechnological Industry partners sought for a MSCA-ITN-ETN proposal

Country of Origin: Hungary
Reference Number: RDHU20191114001
Publication Date: 14 November 2019

Summary

A Hungarian research and technology organization (RTO) is looking for partners from pharma and biotechnological industry to join a H2020 MSCA-ITN-ETN European Training Networks proposal. The proposal will set out a training network including experts from both academic and private enterprises, addressing the various aspects of non-natural peptidic compounds.

Description

The task of the Hungarian RTO is to explore new functional and structural materials and related chemical technologies in the fields of sustainable environment and sustainable health. In the second field, focus is on soft materials important in medical biology, drug carriers, biosensors, and processes taking place in them.
The synergy of their widespread expertise helps to work out interdisciplinary research issues. By answering basic research questions, their research projects are aiming at solving certain social – economic – environmental problems.

The consortium applied for H2020-MSCA-ITN-ETN call in January 2019 but the project was not awarded. They would like to apply again in January 2020 and they wish to find further consortial partners.

The outlined research field is closely related to research actively performed already by the participants of the constellation. Some of the supportive results are fully available via publications. The project proposal aims to deeper the complementary understanding in related areas as well as reach prototype molecular scaffolds ready for specific pharmaceutical-biotechnological developments.

They are looking for partners from the areas of expertise listed bellow:
Biotechnology
Bacterial test
Oncological test
Protein engineering
Peptide sequences
Trans-bilayer transportation
Pharmacological investigation

The optimal partner should provide complementary expertise in the outlined field, potentially in testing either pharmaceutical or biomedical applicability of the compounds developed.

Recruitment/fellowship duration: 3-36 months
Deadline for call: 15 January 2020
Deadline for EOI: 16 December 2019

Advantages and Innovations

The project will aim to reach, by design and investigation, peptidic compounds offering higher selectivity and higher affinity in peptide-protein or peptide-biomembrane interactions, improved metabolic stability, and slower clearance (via efflux).

Stage Of Development

Proposal under development

Requested partner

To strengthen the consortium the RTO is looking for SMEs (Small or Medium Enterprise) from Western Europe: biotechnological SMEs focusing on pharmacological investigation capable of performing diverse protein engineering tasks and LE (Large Corporate) from Western Europe: interested in development of peptide-based bioactive compounds.

Contact Profile Owner